Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P50995: Variant p.Asp40Gly

Annexin A11
Gene: ANXA11
Feedback?
Variant information Variant position: help 40 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Aspartate (D) to Glycine (G) at position 40 (D40G, p.Asp40Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (D) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In ALS23; forms cytoplasmic aggregates in patient tissues; no effect on nuclear and cytoplasmic localization; loss of interaction with S100A6. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 40 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 505 The length of the canonical sequence.
Location on the sequence: help GGPWGGAAYPPPPSMPPIGL D NVATYAGQFNQDYLSGMAAN The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         GGPW-----GGAAYPPPPSMPPIGLDNVATYAGQFNQDYLSGMAAN

Mouse                         GGPW-----GGAGYPPP-SMPPIGLDNVANYAGQFNQDYLS

Bovine                        GGAW-----GGAGYPPP-TMPPIGLDNVANYAGQFNQDYLS

Rabbit                        GGAW-----GGAGYPPP-SMPPIGLDNVANYAGQFNQDYLS

Drosophila                    GAGWVPPMQQNSPYPPPSQPHPHSQPSSQMHPQQHQQ----

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 505 Annexin A11



Literature citations
Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis.
Smith B.N.; Topp S.D.; Fallini C.; Shibata H.; Chen H.J.; Troakes C.; King A.; Ticozzi N.; Kenna K.P.; Soragia-Gkazi A.; Miller J.W.; Sato A.; Dias D.M.; Jeon M.; Vance C.; Wong C.H.; de Majo M.; Kattuah W.; Mitchell J.C.; Scotter E.L.; Parkin N.W.; Sapp P.C.; Nolan M.; Nestor P.J.; Simpson M.; Weale M.; Lek M.; Baas F.; Vianney de Jong J.M.; Ten Asbroek A.L.M.A.; Redondo A.G.; Esteban-Perez J.; Tiloca C.; Verde F.; Duga S.; Leigh N.; Pall H.; Morrison K.E.; Al-Chalabi A.; Shaw P.J.; Kirby J.; Turner M.R.; Talbot K.; Hardiman O.; Glass J.D.; De Belleroche J.; Maki M.; Moss S.E.; Miller C.; Gellera C.; Ratti A.; Al-Sarraj S.; Brown R.H. Jr.; Silani V.; Landers J.E.; Shaw C.E.;
Sci. Transl. Med. 9:0-0(2017)
Cited for: INVOLVEMENT IN ALS23; VARIANTS ALS23 ARG-38; GLY-40; ARG-175; GLU-189; GLN-235 AND CYS-346; CHARACTERIZATION OF VARIANTS ALS23 ARG-38; GLY-40; GLU-189 AND GLN-235; INTERACTION WITH S100A6; SUBCELLULAR LOCATION;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.